World · South & Central Asia · 4 hrs ago
India and US agree to step up action against drug cartels
Officials from India and the United States agreed to strengthen joint action against cross-border drug networks at a meeting in New Delhi on November 2 and 3.
The talks brought together India’s Narcotics Control Bureau and US drug policy officials.
The two countries plan to improve intelligence sharing and coordinated enforcement and to control chemicals used to make synthetic drugs.
They also want to protect pharmaceutical supply chains and disrupt illicit drug financing.
The meeting built on their first working group session, held in Washington, D.C., in January 2026.
Both governments endorsed Operation MedMax, Operation WIPE and a voluntary code to prevent synthetic drug precursors from being diverted.
They also committed to regular exchanges and efforts to reduce drug demand.
India and the United States agreed to strengthen cooperation against transnational drug cartels and synthetic drug trafficking.
Officials met in New Delhi on November 2–3 for the second India–US Drug Policy Executive Working Group Meeting.
The discussions covered intelligence sharing, coordinated enforcement, precursor controls, pharmaceutical supply chains and demand reduction.
The meeting endorsed operational and regulatory initiatives including Operation MedMax, Operation WIPE and India’s Voluntary Code of Conduct.
Both governments reaffirmed their commitment to regular intelligence exchanges and sharing best practices.
- Who
- Officials from India and the United States, including NCB Director General Anurag Garg and Debbie Seguin of the US Office of National Drug Control Policy.
- What
- They agreed to step up cooperation against transnational drug cartels and synthetic drug trafficking.
- When
- November 2–3. The year is not stated for the meeting.
- Where
- New Delhi, India.
- Why
- To counter transnational drug networks and address synthetic drug flows, illicit financing and diversion of chemicals and pharmaceuticals.
This story does not have two clearly opposing sides.
India and the United States held their inaugural Drug Policy Executive Working Group meeting in Washington, D.C.
The countries held the second working group meeting in New Delhi.
Both governments endorsed operational and regulatory milestones and reaffirmed their commitment to regular intelligence exchanges and demand reduction.
- Meeting
- Second India–US Drug Policy Executive Working Group Meeting
- Location
- New Delhi
- Meeting dates
- November 2–3
- Indian delegation leader
- Anurag Garg, NCB Director General
- US delegation leader
- Debbie Seguin, acting deputy director of the Office of National Drug Control Policy
- Endorsed initiatives
- Operation MedMax, Operation WIPE and India’s Voluntary Code of Conduct
What people are saying
India has transitioned to a robust, network-centric enforcement model designed to dismantle the entire illicit ecosystem by targeting kingpins, financiers, chemical suppliers, and logistical facilitators rather than street-level operatives alone.
bilateral cooperation is vital to neutralizing transnational cartels that now operate like sophisticated multinational logistics enterprises.
both countries are actively choking off illicit precursor chemicals and dismantling cartels through high-trust, rapid law enforcement coordination that safeguards families in both nations.